ANCA-Associated Vasculitis: Clinical Trials

1 trial for ANCA-Associated Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Not yet recruiting 1

Follow ANCA-Associated Vasculitis: new trials by email Literature Review of ANCA-Associated Vasculitis trials Research Report on ANCA-Associated Vasculitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV
RD06-04 Cell Injection Infusion - Idiopathic Inflammatory Myopathies, ANCA-Associated Vasculitis
Early Phase 1Not yet recruitingPeking University People's Hospital122025-06-142025-05-22

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Myositis (1)

Broader conditions

Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Immune System Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Systemic Vasculitis (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Sponsors

Peking University People's Hospital (1)

Countries

China (1)